Home › Funds › Invesco Ltd › STRO
Invesco Ltd position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)57.30K sh
Reported value held$1.90M
Portfolio Weight0.00%
First reportedQ3 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 345.24K | $6.52M | New |
| Q4 2021 | 166.22K | $2.47M | Reduce |
| Q1 2022 | 54.13K | $445.00K | Reduce |
| Q2 2022 | 61.32K | $320.00K | Add |
| Q3 2022 | 59.30K | $329.00K | Reduce |
| Q4 2022 | 62.74K | $506.94K | Add |
| Q1 2023 | 19.44K | $89.83K | Reduce |
| Q2 2023 | 21.78K | $101.29K | Add |
| Q3 2023 | 21.39K | $74.21K | Reduce |
| Q4 2023 | 30.62K | $131.38K | Add |
| Q1 2024 | 26.20K | $148.03K | Reduce |
| Q2 2024 | 26.26K | $76.94K | Hold |
| Q3 2024 | 25.13K | $86.95K | Reduce |
| Q4 2024 | 38.75K | $71.30K | Add |
| Q1 2025 | 92.14K | $59.95K | Add |
| Q2 2025 | 103.32K | $73.76K | Add |
| Q3 2025 | 134.92K | $117.16K | Add |
| Q4 2025 | 16.97K | $196.34K | Reduce |
| Q1 2026 | 17.16K | $427.58K | Add |
| Q2 2026 | 57.30K | $1.90M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026